| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
4,540,000 |
| Market
Cap: |
14.66(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.15 - $6.931 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Aileron Therapeutics is a clinical stage chemoprotection oncology company. ALRN-6924, Co.'s MDM2/MDMX dual inhibitor, is designed to activate p53, which in turn upregulates p21, a known inhibitor of the cell replication cycle. ALRN-6924 is a chemoprotective agent in clinical development to employ a biomarker strategy, in which Co. focuses on treating patients with p53-mutated cancers. Co.'s clinical development program for ALRN-6924 as a selective chemoprotective agent includes: Its completed Phase 1b open-label clinical trial evaluating ALRN-6924 as a chemoprotective agent in patients with p53-mutated small cell lung cancer, undergoing treatment with second-line topotecan.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
225 |
5,301 |
5,301 |
| Total Buy Value |
$0 |
$758 |
$10,745 |
$10,745 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
2 |
2 |
| Total Shares Sold |
63,781 |
63,781 |
63,781 |
63,781 |
| Total Sell Value |
$265,104 |
$265,104 |
$265,104 |
$265,104 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
7 |
7 |
7 |
7 |
| End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Novartis Ag |
10% Owner |
– – • |
2018-07-27 |
4 |
S |
$3.38 |
$21,828 |
D/D |
(6,458) |
2,473,227 |
|
- |
|
| Novartis Ag |
10% Owner |
– – • |
2018-07-26 |
4 |
S |
$3.63 |
$28,811 |
D/D |
(7,937) |
2,479,685 |
|
- |
|
| Novartis Ag |
10% Owner |
– – • |
2018-07-25 |
4 |
S |
$3.84 |
$47,846 |
D/D |
(12,460) |
2,487,622 |
|
- |
|
| Novartis Ag |
10% Owner |
– – • |
2018-07-24 |
4 |
S |
$4.11 |
$2,877 |
D/D |
(700) |
2,500,082 |
|
- |
|
| Novartis Ag |
10% Owner |
– – • |
2018-07-23 |
4 |
S |
$4.25 |
$130,050 |
D/D |
(30,600) |
2,500,782 |
|
- |
|
| Novartis Ag |
10% Owner |
– – • |
2018-07-17 |
4 |
S |
$4.71 |
$58,875 |
D/D |
(12,500) |
2,531,382 |
|
- |
|
| Novartis Ag |
10% Owner |
– – • |
2018-07-16 |
4 |
S |
$5.15 |
$1,545 |
D/D |
(300) |
2,543,882 |
|
- |
|
| Apple Tree Partners Ii - Annex, L.p. |
10% Owner |
– – • |
2018-07-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(655,797) |
0 |
|
- |
|
| Apple Tree Partners Ii Lp |
10% Owner |
– – • |
2018-07-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,380,241) |
0 |
|
- |
|
| Apple Tree Partners Ii Lp |
10% Owner |
– – • |
2018-06-26 |
4 |
S |
$5.45 |
$57,425 |
D/D |
(10,528) |
1,380,241 |
|
- |
|
| Apple Tree Partners Ii Lp |
10% Owner |
– – • |
2018-06-25 |
4 |
S |
$5.86 |
$5,353 |
D/D |
(913) |
1,390,769 |
|
- |
|
| Apple Tree Partners Ii Lp |
10% Owner |
– – • |
2018-06-22 |
4 |
S |
$5.98 |
$566,744 |
D/D |
(94,816) |
1,391,682 |
|
- |
|
| Apple Tree Partners Ii Lp |
10% Owner |
– – • |
2018-06-21 |
4 |
S |
$5.30 |
$7,669 |
D/D |
(1,447) |
1,486,498 |
|
- |
|
| Apple Tree Partners Ii Lp |
10% Owner |
– – • |
2018-06-20 |
4 |
S |
$5.30 |
$27,564 |
D/D |
(5,200) |
1,487,945 |
|
- |
|
| Apple Tree Partners Ii Lp |
10% Owner |
– – • |
2018-06-19 |
4 |
S |
$5.30 |
$737 |
D/D |
(139) |
1,493,145 |
|
- |
|
| Apple Tree Partners Ii Lp |
10% Owner |
– – • |
2018-06-18 |
4 |
S |
$5.35 |
$7,661 |
D/D |
(1,432) |
1,493,284 |
|
- |
|
| Apple Tree Partners Ii Lp |
10% Owner |
– – • |
2018-06-15 |
4 |
S |
$5.32 |
$42,345 |
D/D |
(7,961) |
1,494,716 |
|
- |
|
| Apple Tree Partners Ii Lp |
10% Owner |
– – • |
2018-06-12 |
4 |
S |
$5.40 |
$58,558 |
D/D |
(10,843) |
1,502,677 |
|
- |
|
| Apple Tree Partners Ii Lp |
10% Owner |
– – • |
2018-06-11 |
4 |
S |
$5.41 |
$100,242 |
D/D |
(18,525) |
1,513,520 |
|
- |
|
| Dougherty Donald |
SVP & Chief Financial Officer |
• – – |
2018-06-08 |
4 |
B |
$5.40 |
$16,200 |
D/D |
3,000 |
5,000 |
2.74 |
- |
|
| Apple Tree Partners Ii Lp |
10% Owner |
– – • |
2018-06-08 |
4 |
S |
$5.40 |
$51,963 |
D/D |
(9,617) |
1,532,045 |
|
- |
|
| Apple Tree Partners Ii Lp |
10% Owner |
– – • |
2018-06-07 |
4 |
S |
$5.48 |
$110 |
D/D |
(20) |
1,541,662 |
|
- |
|
| Aivado Manuel |
See Remarks |
• – – |
2018-06-06 |
4 |
B |
$5.61 |
$5,610 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| Dougherty Donald |
SVP & Chief Financial Officer |
• – – |
2018-06-01 |
4 |
B |
$5.24 |
$10,480 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
| Apple Tree Partners Ii Lp |
10% Owner |
– – • |
2018-04-19 |
4 |
S |
$6.29 |
$659,500 |
D/D |
(104,799) |
1,541,682 |
|
- |
|
108 Records found
|
|
Page 3 of 5 |
|
|
0.05 (1.57%) 
